![]() Steiner and Luschbaugh first described amniotic fluid embolism in 1941, after they found fetal cells in the maternal pulmonary circulation, who died during labor. In the United States, AFE occurs in 2 to 8 per 100,000 deliveries and is the cause of maternal mortality between 7.5% to 10%. Survivors are frequently left with serious cardiac, renal, neurologic, and pulmonary dysfunction. The presentation is abrupt, usually with sudden cardiorespiratory collapse followed by severe coagulopathy and refractory resuscitation. Amniotic fluid embolism (AFE) represents the second leading cause of peripartum maternal death in the United States and the number one cause of peripartum cardiac arrest. Explain the importance of improving care coordination among the interprofessional team to enhance the delivery of care for a woman who has sustained amniotic fluid embolism.Īmniotic fluid embolism (AFE) is a life-threatening obstetric emergency characterized by sudden cardiorespiratory collapse and disseminated intravascular coagulation.Outline correct methods of analyzing coagulation parameters and how to treat them once they are determined.Describe the triggering pulmonary pathology that initiates the syndrome of amniotic fluid embolism.Identify the underlying risk factors for amniotic fluid embolism.This activity reviews the evaluation and management of AFE and highlights the role of the interprofessional team in evaluating and improving care for patients with this condition. This article will explain the clinical presentation of AFE, including a detailed description of the pathophysiology, and the very complicated evaluation and treatment modalities. ![]() Amniotic fluid embolism (AFE) is a rare entity, but one which has very high mortality and morbidity rates.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |